Maxigen Biotech Inc. reported consolidated revenue results for the month and year-to-date ended September 2022. For the month, On a consolidated basis, revenues for September 2022 were approximately TWD 59.273 million, an increase of 7.01% over the same period in 2021.
For the year-to-date, the company reported Revenues for January through September 2022 totaled TWD 440.124 million, an increase of 18.74% compared to the TWD 370.649 million for the same period in 2021.